Press Release
Imagine Pharma Completes More Than 32 Clinical Human Islet Cell Isolation Procedures for Leading Hospital Systems in 2023
Dec 19, 2023
Read More
Press Release
Imagine Pharma Secures $32.5M Series A for Continued Development of Its Novel IMG-1 Polypeptide and Associated Programs
Oct 31, 2023
Read More
Press Release
LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes
Apr 11, 2023
Read More
Press Release
Imagine Pharma Awarded Contract from National Institute of Diabetes and Digestive and Kidney Diseases’s Integrated Islet Distribution Program to Provide Human Islets
Aug 2, 2022
Read More
Event
San Diego, CA Meet Imagine Pharma at the 2022 Drug Delivery & Formulation Summit (Sept. 26-27, 2022)
Jul 13, 2022
Read More
Event
New Orleans, LA Meet Imagine Pharma at the 64th Annual ASH Meeting (December 10-13, 2022)
Jul 13, 2022
Read More
Press Release
Imagine Pharma Unveils Industry-First Generation of Insulin-Producing T1D Islet Cell Population at the American Transplant Congress
Jun 6, 2022
Read More
Presentation
ATC 2022 Generation of Insulin-Producing Cells From Pancreatic Tissue With Long Standing Type 1 Diabetes
Jun 4, 2022
Download
Poster
ATC 2022 Characterization of Activated Islet Progenitor Cells (AIPCs) During Maturation to De Novo-Islets
May 28, 2022
Download
Event
Meet Imagine Pharma at ATC2022
May 19, 2022
Read More
Poster
IMG-1 Normalizes Blood Glucose Levels by Inhibiting Glucagon Levels in ZDF Rats
Jun 18, 2018
Download
Poster
IMG-1 Reduces Blood Glucose Levels in Rat and Mouse STZ Models
Jun 18, 2018
Download
Poster
IMG-1 Lowers Insulin Resistance by Decreasing Hepatic Glucose Production in a DIO Mouse Clamp Test
Jun 18, 2018
Download
